Morgan Stanley Upgrades Cemex to Overweight, Maintains Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 88.2%

Neg 0% Neu 0% Pos 88.2%

Morgan Stanley analyst Nikolaj Lippmann upgrades Cemex (NYSE:CX) from Equal-Weight to Overweight and maintains the price target from $14 to $14.